Nolato AB — Cyborg Score 7/10

Strong
Specialty Plastics & Polymer Manufacturing; Medical Device Contract Manufacturing

Strategic Profile

Nolato operates through three core segments (Medical, Integrated, and Industrial) providing end-market diversification and exposure to growth sectors including life sciences and medical devices. The company combines deep polymer chemistry expertise with advanced manufacturing capabilities (injection molding, silicone processing, assembly) and positions itself as a design-to-manufacturing partner for sophisticated, regulated applications.

Cyborg Score Rationale

Nolato demonstrates solid fundamentals with $9.66B revenue (2024), approximately 5,500 employees, and diverse end-market exposure. Recent earnings growth of 51% YoY (2024) reflects operational leverage and market demand recovery. The company benefits from secular tailwinds in medical devices and pharmaceuticals, though integration complexity and cyclical consumer electronics exposure present headwinds.

Top Insights

  • Operating in three strategic segments (Medical, Integrated, Industrial) provides balanced exposure to both growth markets (medical devices, pharmaceuticals) and cyclical sectors (consumer electronics, automotive)
  • Contract manufacturing and design-to-production capabilities serve as competitive moats in regulated industries requiring ISO/quality certifications and established supply chain relationships
  • Significant geographic diversification with operations across Europe (approximately one-third of revenue from Rest of Europe), Asia, and North America reduces regional economic exposure
  • Recent 51% earnings growth in 2024 versus modest 1.24% revenue growth suggests operational optimization and margin expansion opportunities post-pandemic normalization

Named Competitors

  • Specialty Polymers & Contract Manufacturing — Large diversified chemical company with specialty polymers and regulated market presence
  • Elastomer & Polymer Solutions — European competitor in specialized elastomer sealing and damping solutions
  • Polymer Products Manufacturing — Global materials company serving medical, consumer electronics, and industrial sectors

Recent Developments

  • (February 2026) Q4 2025 earnings release
  • (2024) 51% year-over-year earnings growth despite flat revenue growth, indicating margin expansion
  • (2024) Revenue of 9.66B SEK, up 1.24% from prior year

Open the full interactive Nolato AB report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →